In:
Obstetrical & Gynecological Survey, Ovid Technologies (Wolters Kluwer Health), Vol. 72, No. 9 ( 2017-9), p. 531-533
Abstract:
(Abstracted from Am J Obstet Gynecol 2017;216:500.e1–500.e11) Although uterine fibroids are a common problem among reproductive-aged women, few comparative effectiveness studies are available to guide treatment decisions. Two minimally invasive treatments—uterine artery embolization (UAE) and magnetic resonance imaging–guided focused ultrasound surgery (MRgFUS)—have been approved by the US Food and Drug Administration for treatment of symptomatic uterine fibroids.
Type of Medium:
Online Resource
ISSN:
1533-9866
,
0029-7828
DOI:
10.1097/OGX.0000000000000478
Language:
English
Publisher:
Ovid Technologies (Wolters Kluwer Health)
Publication Date:
2017
detail.hit.zdb_id:
2043471-6
Permalink